Effect of Anti CD20 in Pemphigus Desease

• Status: Completed
• Trial end date: 2008-10-01
• Target enrollment: 0
• Participant gender: All

Summary

to treat in an open non comparative clinical study patients presenting pemphigus with corticodependance, corticoresistance and contre-indication to systemic steroids.

• Phase: Phase 2/Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University Hospital, Rouen
• Treatments: Rituximab

Criteria

Inclusion Criteria:

• age>18

• pemphigus corticoresistant

• pemphigus cortico dependant

• contre-indications : systémic steroids

Exclusion Criteria:

• age < 18

• cardiopathie

• pregnant woman

• absence contraception

• no consentment